Cite
HARVARD Citation
Jung, C. et al. (n.d.). A randomized, double‐blind, placebo‐controlled, phase II clinical trial to investigate the efficacy and safety of oral DA‐1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise. Diabetes/metabolism research and reviews. 31 (3), pp. 295-306. [Online].